Meet Our Experienced Multidisciplinary Team

Hardian brings together a multidisciplinary team of experienced clinicians, regulatory experts, and specialists in intellectual property, health economics and market strategy.

Dr Hugh Harvey

Dr Hugh Harvey,
Managing Director

MBBS BSc(Hons) FRCR MD(Res) FBIR

Hugh is an ex-consultant radiologist, academic and entrepreneur. He has helped bring to market dozens of SaMD including artificial intelligence systems, and is widely published and renowned for his insight into the healthtech landscape.

Mike Pogose

Michael Pogose, Director - Quality Assurance & Regulatory Affairs

BEng (Hons) MSc CEng MIET MAPM

Mike specialises in Quality Assurance and Regulatory Affairs for medical devices, particularly SaMD. A qualified auditor and software engineer, he has worked in a range of SMEs at various stages of maturity and growth.

Headshot of Sarah Bell, Operations Manager

Sarah Bell,
Operations Manager

MDrama BA Hons 

Sarah is a highly skilled operations and management professional with over a decade of experience. With a strong track record of delivering results and driving growth, Sarah has developed a reputation for excellence in strategic planning, project management, and team leadership.

Lucy Gregory

Lucy Gregory,
Consultant - Health Economics

BSc, Msc

Lucy holds a first-class degree in BSc Economics and an MSc in International Health Policy (Health Economics) from The London School of Economics with a special interest in healthtech.

Ana Ribeiro

Ana Ribeiro, Associate - Quality Assurance & Regulatory Affairs

BSC, MRes

Ana is a trained healthcare professional in oncological imaging, with over 15 yearsโ€™ in the NHS. Holding a masterโ€™s degree in clinical research, she has managed a diverse portfolio of clinical studies in the fields of AI and Imaging.

Ankeet Tanna

Dr Ankeet Tanna, Consultant - Clinical

MA, MB BChir

Ankeet is a Cambridge-trained doctor with experience developing machine learning tools for dementia. He has a special interest in the intersection between the clinical validation and health economic value of clinical AI.

Ben Howes

Ben Howes, Consultant - Quality Assurance & Regulatory Affairs

MEng (HONS)

Ben is a software engineering professional and CTO with over 10 years of experience in delivering complex software solutions, with experience in creating SaMD devices at a startup medical device manufacturer.

Felicity Lock

Dr Felicity Lock, Associate - Clinical

MBBCh BSc 

Felicity trained in both medicine and biomedical engineering and has worked as a NHS doctor. She is interested in the collaboration between the health and tech sectors to foster patient-centred innovation.

Dr Joe Antoun

Dr Joe Antoun, Associate - Clinical

BSC, PHD

Joe is a PhD graduate in clinical physiology with expertise in health research, particularly interested in the intersection between health and data science.

Advisory team

Daniel Revell Ward

Daniel Revell Ward - Strategy

BA(HONS), MSc

Previously Head of Digital Investment Strategy, NHSX / NHS England, Daniel supports Hardian clients in NHS market access and adoption of digital innovations across the NHS.

Annemijn Eschauzier

Annemijn Eschauzier, Consultant - GTM, Strategy & Pricing

LLB, BSc

As an enthusiastic, driven healthcare marketing professional and lifelong coach and mentor with more than 25+ years of experience, Annemijn has a strong passion for helping people and healthcare organisations transform their business.

Trishal Boodhna

Dr Trishal Boodhna, Senior Consultant - Health Economics

PhD, MSc, BSc

Trishal is an experienced health economist whose work revolves around the construction of economic models and to deliver strategic consultation for technology value assessment.

Stephen Carter

Stephen Carter, Senior Consultant - IP And Patenting

BEng, MPhil

Stephen is Hardianโ€™s Intellectual Property consultant, and a European Patent Attorney and Chartered UK Patent Attorney and has particular experience in healthtech. He is recognised in the โ€˜iam 300โ€™ as one of the worldโ€™s leading IP strategists.

Seth Flaxman

Prof Seth Flaxman, Consultant - Statistics & Machine Learning

BA, PhD

Seth is an associate professor in the Department of Computer Science at Oxford. He has a BA with honours from Harvard University and a PhD in machine learning from Carnegie Mellon University.

Julia Sus

Julia Sus, Senior Consultant - Health Technology Assessment

BSc , MPH

Julia is a health economist who previously led a team at NICE designing, building and assessing health economic evaluations for formal nationwide reimbursement of health interventions.

Marc Barlow

Marc Barlow, Consultant - GTM & Strategy

Bsc biological sciences

Marc is an experienced healthcare consultant with 40 years commercial experience in pharmaceutical and Med Tech markets at leading corporates such as GE and Sanofi-Aventis

Jeffry Hogg

Dr Jeffry Hogg, Clinical Researcher

MBBS, MRes, FHEA, PhD(c)

Jeff is an ophthalmology registrar and academic. He specialises in the factors that influence the implementation of clinical decision support across clinical and organisational contexts.

Heenal Singh

Heenal Singh, Analyst - Health Economics

MPharm, MSc

Heenal is a pharmacist and health economist with experience in statistical analyses, health economic models and systematic reviews.